Robbins Geller Launches Investigation into Travere Therapeutics

Law firm encourages investors and potential witnesses to contact them regarding alleged securities violations

Jan. 30, 2026 at 8:15pm

Got story updates? Submit your updates here. ›

Robbins Geller Rudman & Dowd LLP, a leading securities litigation law firm, has launched an investigation into Travere Therapeutics, Inc. (NASDAQ: TVTX) and certain of its top executives. The investigation is focused on determining whether the company and its executives made materially false and/or misleading statements and/or omitted material information regarding Travere's business and operations.

Why it matters

Travere Therapeutics is a biopharmaceutical company that develops therapies for rare kidney and metabolic diseases. The investigation by Robbins Geller, a prominent securities litigation firm, suggests potential issues with the company's disclosures and could have significant implications for Travere's investors and the broader pharmaceutical industry.

The details

Robbins Geller is investigating whether Travere and certain of its executives made materially false and/or misleading statements and/or omitted material information regarding the company's business and operations. The law firm is encouraging investors who have suffered losses and potential witnesses to contact them to assist with the investigation.

  • The investigation was launched on January 30, 2026.

The players

Travere Therapeutics, Inc.

A biopharmaceutical company that develops therapies for people living with rare kidney and metabolic diseases in the United States.

Robbins Geller Rudman & Dowd LLP

A leading law firm representing investors in securities fraud and shareholder litigation, ranked #1 in the ISS Securities Class Action Services rankings for four out of the last five years for securing the most monetary relief for investors.

J.C. Sanchez

An attorney at Robbins Geller Rudman & Dowd LLP who is encouraging investors and potential witnesses to contact the firm regarding the investigation.

Got photos? Submit your photos here. ›

What they’re saying

“You can provide your information here: https://www.rgrdlaw.com/cases-travere-therapeutics-inc-investigation-tvtx.html”

— J.C. Sanchez, Attorney, Robbins Geller Rudman & Dowd LLP (Robbins Geller Rudman & Dowd LLP)

“You can also contact attorney J.C. Sanchez of Robbins Geller by calling 800/449-4900 or via e-mail at info@rgrdlaw.com.”

— J.C. Sanchez, Attorney, Robbins Geller Rudman & Dowd LLP (Robbins Geller Rudman & Dowd LLP)

What’s next

The judge in the case will decide on whether to allow the investigation to proceed.

The takeaway

This investigation by a prominent securities litigation firm suggests potential issues with Travere Therapeutics' disclosures, which could have significant implications for the company's investors and the broader pharmaceutical industry. The outcome of the investigation will be closely watched.